Reports
Sale
Global Healthcare Contract Manufacturing Market Size, Share, Forecast: By Service: Medical Device, Pharmaceutical; By Type: Sterile, Non-Sterile; By Class: Class I, Class II, Class III; By Type of Manufacturing: Raw Material, Electronics, Finished Goods; By End User: Medical Device Companies, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Healthcare Contract Manufacturing Market Outlook
The global healthcare contract manufacturing market size was valued at USD 238.5 billion in 2023, driven by the increasing technical advancements in diagnostic tools across the globe. The market size is anticipated to grow at a CAGR of 9.44% during the forecast period of 2024-2032 to achieve a value of USD 537.1 billion by 2032.
Healthcare Contract Manufacturing: Introduction
Medical device contract manufacturing is a process where a MedTech company uses the help of drug manufacturing companies to formulate and develop their patented and authorized drugs and take care of the further process in the market. A company working for another company on their behalf due to the absence of hardware and area to perform the whole research, formulation and development and manufacturing of drugs on a contract-based relationship, is known as healthcare contract manufacturing.
There are several benefits that a MedTech company avails while in contract with the manufacturing company, such as cost-optimized manufacturing of drugs, the availability of experience and technology across various segments that can be utilized to upscale the project. The contract also provides with effective regulatory compliant manufacturing, increased access across various parts of the globe to maximize the networking and reach of the products.
Pharmaceutical contract manufacturing is the process in which pharmaceutical drugs are manufactured on a contract basis. There are several types of drugs and ways they are administered, but the most common drug delivery systems are oral, topical, and parenteral (injection).
Global Healthcare Contract Manufacturing Market Analysis
The increased outsourcing by pharmaceutical companies and other medical companies to cut on their production expenditures and add on to the efforts and expenses on marketing of those drugs is a major key trend in the market driving the healthcare contract manufacturing market growth. The demand for more advanced formulated and personalized drug treatments are also increasing the demand.
Additionally, the increasing number of medical patients and noninvasive surgical procedures are directly increasing the demand for pharmaceutical drugs globally. To curb this increased demand, pharmaceutical companies are taking help of healthcare contract manufacturing companies.
Global Healthcare Contract Manufacturing Market Segmentations
Market Breakup by Service
- Medical Device
- Service
- Accessories Manufacturing
- Assembly Manufacturing
- Component Manufacturing
- Device Manufacturing
- Therapeutic Area
- Cardiology
- Diagnostic Imaging
- Orthopaedic
- IVD
- Ophthalmic
- General and Plastic Surgery
- Drug Delivery
- Dental
- Endoscopy
- Diabetes Care
- Others
- Pharmaceutical
- Service
- API/Bulk Drugs
- Advanced Drug Delivery Formulation
- Packaging
- Finished Dose Formulations
- Solid
- Liquid
- Semisolid
Market Breakup by Type
- Sterile
- Non-Sterile
Market Breakup by Class
- Class I
- Class II
- Class III
Market Breakup by Type of Manufacturing
- Raw Material
- Electronics
- Finished Goods
Market Breakup by End User
- Medical Device Companies
- Pharmaceutical Companies
- Biopharmaceutical Companies
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Healthcare Contract Manufacturing Market Overview
The pharmaceutical manufacturing process is evolving. The development of drugs involves years of research and testing to come up to a decision where it is confirmed that the research is through and now the manufacturing and applications may be put to use in the market. Increasing advancements in manufacturing technologies, such as continuous manufacturing, single-use technologies, and 3D printing, among others, can also potentially drive the market. The increased pressure to reduce costs and improve operational efficiency is also a significant driver for healthcare contract manufacturing market expansion.
Additionally, manufacturing safe and stable drugs is an expensive task. Hence, partnering with an industry leading CMO/CDMO gives companies new opportunities in complicated drug manufacturing market. The increasing patient population worldwide is a major driver driving the healthcare contract manufacturing market expansion as the demand for drugs manufacturing and administration is increased. Due to the low risk of product carryover and resulting market expansion, the utilization of multi product facilities to create biologics has been shown to be both economically effective and secure aiding the expansion of healthcare contract manufacturing market development.
Global Healthcare Contract Manufacturing Market Share by Region
Geographically, the North America is leading the global market due to the presence of multiple key players in the region. The growth of the market can be attributed to the developed and rapidly advancing healthcare sector in the region, along with the rising presence of the key players in the region.
Global Healthcare Contract Manufacturing Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific
- Lonza
- Celestica Inc.
- Integer Holdings Corporation
- Nordson Corporation
- Sanmina Corporation
- Phillips-Medisize - a Molex Company
- Catalent, Inc
- Boehringer Ingelheim International GmbH
- Samsung Biologics
- WuXi AppTec
- Cambrex Corporation
- Recifarm
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Service |
|
| Breakup by Type |
|
|
Breakup by Class |
|
| Breakup by Type of Manufacturing |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Healthcare Contract Manufacturing Market Overview
3.1 Global Healthcare Contract Manufacturing Market Historical Value (2017-2023)
3.2 Global Healthcare Contract Manufacturing Market Forecast Value (2024-2032)
4 Global Healthcare Contract Manufacturing Market Landscape
4.1 Global Healthcare Contract Manufacturing Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Healthcare Contract Manufacturing Product Landscape
4.2.1 Analysis by Service
4.2.2 Analysis by Type
4.2.3 Analysis by Class
4.2.4 Analysis by Type of Manufacturing
5 Global Healthcare Contract Manufacturing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Healthcare Contract Manufacturing Market Segmentation
6.1 Global Healthcare Contract Manufacturing Market by Service
6.1.1 Market Overview
6.1.2 Medical Device
6.1.2.1 Service
6.1.2.1.1 Accessories Manufacturing
6.1.2.1.2 Assembly Manufacturing
6.1.2.1.3 Component Manufacturing
6.1.2.1.4 Device Manufacturing
6.1.2.2 Therapeutic Area
6.1.2.2.1 Cardiology
6.1.2.2.2 Diagnostic Imaging
6.1.2.2.3 Orthopaedic
6.1.2.2.4 IVD
6.1.2.2.5 Ophthalmic
6.1.2.2.6 General and Plastic Surgery
6.1.2.2.7 Drug Delivery
6.1.2.2.8 Dental
6.1.2.2.9 Endoscopy
6.1.2.2.10 Diabetes Care
6.1.2.2.11 Others
6.1.3 Pharmaceutical
6.1.3.1 Service
6.1.3.1.1 API/Bulk Drugs
6.1.3.1.2 Advanced Drug Delivery Formulation
6.1.3.1.3 Packaging
6.1.3.1.4 Finished Dose Formulations
6.1.3.1.4.1 Solid
6.1.3.1.4.2 Liquid
6.1.3.1.4.3 Semisolid
6.2 Global Healthcare Contract Manufacturing Market by Type
6.2.1 Market Overview
6.2.2 Sterile
6.2.3 Non-Sterile
6.3 Global Healthcare Contract Manufacturing Market by Class
6.3.1 Market Overview
6.3.2 Class I
6.3.3 Class II
6.3.4 Class III
6.4 Global Healthcare Contract Manufacturing Market by Type of Manufacturing
6.4.1 Market Overview
6.4.2 Raw Material
6.4.3 Electronics
6.4.4 Finished Goods
6.5 Global Healthcare Contract Manufacturing Market by End User
6.5.1 Market Overview
6.5.2 Medical Device Companies
6.5.3 Pharmaceutical Companies
6.5.4 Biopharmaceutical Companies
6.6 Global Healthcare Contract Manufacturing Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Healthcare Contract Manufacturing Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Healthcare Contract Manufacturing Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Healthcare Contract Manufacturing Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Healthcare Contract Manufacturing Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Healthcare Contract Manufacturing Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Thermo Fisher Scientific
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Lonza
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Celestica Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Integer Holdings Corporation
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Nordson Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Sanmina Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Phillips-Medisize - a Molex Company
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Catalent, Inc
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Boehringer Ingelheim International GmbH
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Samsung Biologics
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 WuXi AppTec
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Cambrex Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Recifarm
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Healthcare Contract Manufacturing Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 238.5 billion in 2023, driven by the rising prevalence of eye disorders.
The global market is anticipated to grow at a CAGR of 9.44% during the forecast period of 2024-2032 and reach a market value of USD 537.1 billion by 2032.
Increasing advancements in manufacturing technologies, such as continuous manufacturing and single-use technologies, among others are some of the key factors aiding the growth of the market.
The increase in outsourcing by pharmaceutical companies and other medical companies to cut on their production costs and invest it on the marketing of that drug is a major trend aiding the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa, with North America leading the global market.
The different types of services in the market include medical devices and pharmaceuticals, which are further broken into sub-categories.
The types in the market can be categorised into sterile and non-sterile.
The different classes in the market are class I, class II, and class III.
The types of manufacturing in the market are raw material, electronics, and finished goods.
The end users in the market are medical device companies, pharmaceutical companies, and biopharmaceutical companies.
Key players involved in the market are Thermo Fisher Scientific, Lonza, Celestica Inc., Integer Holdings Corporation, Nordson Corporation, Sanmina Corporation, Phillips-Medisize - a Molex Company, Catalent, Inc, Boehringer Ingelheim International GmbH, Samsung Biologics, WuXi AppTec, Cambrex Corporation, and Recifarm.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER